Home › Companies › CLOVER HEALTH INVESTMENTS CORP. › 2024-2025

CLOVER HEALTH INVESTMENTS CORP. 2024-2025 Proxy Voting Records

Compiled from SEC Form N-PX filings and CLOVER HEALTH INVESTMENTS CORP.’s Form 8-K, filed 2025-06-12 (Item 5.07 on EDGAR). Page generated 02 October 2026.

  • 4Ballot items
  • 130Asset managers
  • 376Fund votes
  • 2025-06-10Meeting date

Proxy season: 2023-2024 2024-2025 2025-2026

Explore CLOVER HEALTH INVESTMENTS CORP. in the interactive database Compare manager voting policies

Official 2024-2025 meeting results reported by CLOVER HEALTH INVESTMENTS CORP.

These tallies are CLOVER HEALTH INVESTMENTS CORP.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed 2025-06-12 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.

CLOVER HEALTH INVESTMENTS CORP. — official shareholder meeting results, meeting held 2025-06-10
Ballot itemForAgainst AbstainWithheldBroker non-votesOutcome
Elect Director: Anna U. Loengard, M.D. 976,901,062---- 20,121,520161,993,043 Majority: yes
Elect Director: William G. Robinson, Jr. 969,995,918---- 27,026,664161,993,043 Majority: yes
Proposal 2: Non-binding advisory vote to approve the compensation of the Company's Named Executive Officers for 2024 988,724,2806,196,9822,101,320 --161,993,043 Majority: yes
Proposal 3: Ratification of the appointment of Ernst & Young LLP as independent registered public accounting firm for the fiscal year ending December 31, 2025 1,154,406,0353,060,0801,549,510 ---- Majority: yes

Source: CLOVER HEALTH INVESTMENTS CORP., Form 8-K, filed with the SEC on 2025-06-12 — read the filing on EDGAR.

How asset managers voted at the CLOVER HEALTH INVESTMENTS CORP. 2024-2025 meeting

Each item below shows how the 130 asset managers that disclosed a CLOVER HEALTH INVESTMENTS CORP. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report.

1. Non-binding advisory proposal to approve the compensation paid to our named executive officers for 2024.

SECTION 14A SAY-ON-PAY VOTESMajority of the votes cast: yes

Combines 10 wordings of this item as funds reported it.

99.3% Majority: yes · of votes cast

FOR 99.3%
FOR: 988,724,280AGAINST: 6,196,982

CLOVER HEALTH INVESTMENTS CORP.’s own tally for this item (“Proposal 2: Non-binding advisory vote to approve the compensation of the Company's Named Executive Officers for 2024”): 988,724,280 for, 6,196,982 against, per its Form 8-K filed 2025-06-12 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Share-of-outstanding not shown: votes cast exceed the reported share count, which usually means multiple share classes with different voting rights.

The 127 asset managers below cast 98% of the shares they voted on this item FOR (73,209,862 for, 1,181,175 against).

FOR 98%
FOR: 73,209,862 (98.3%)AGAINST: 1,181,175 (1.6%)ABSTAIN: 116,325 (0.2%)
Largest asset managers voting on “Non-binding advisory proposal to approve the compensation paid to our named executive officers for 2024.” at CLOVER HEALTH INVESTMENTS CORP., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard20,835,5480 00For
Renaissance8,814,5560 00For
BlackRock8,379,4060 00For
Charles Schwab5,285,2670 00For
GEODE CAPITAL MANAGEMENT, LLC5,063,2120 00For
Fidelity4,562,0870 00For
State Street3,105,2350 00For
MARSHALL WACE, LLP2,599,1270 00For
Invesco2,257,5370 00For
American Century1,831,1500 00For
First Trust1,495,3710 00For
Citadel1,260,0720 00For
Northern Trust995,7660 00For
Victory Capital762,5960 00For
GMT CAPITAL CORP701,6000 00For
Connor, Clark & Lunn Investment Management Ltd.651,3550 00For
JUPITER ASSET MANAGEMENT LTD647,7770 00For
TEACHER RETIREMENT SYSTEM OF TEXAS571,3380 00For
UBS0515,152 00Against
Allianz0367,162 00Against
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM351,4460 00For
Legal & General Investment Management Ltd0290,761 00Against
JPMorgan285,7160 00For
OMERS ADMINISTRATION Corp206,2000 00For
SECTORAL ASSET MANAGEMENT INC183,0000 00For

Showing the 25 largest of 127 asset managers. See all 127 in the interactive database.

2. DIRECTOR: ANNA U. LOENGARD, M.D.

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 4 wordings of this item as funds reported it.

98% Majority: yes · of votes cast

FOR 98%
FOR: 976,901,062WITHHELD: 20,121,520

CLOVER HEALTH INVESTMENTS CORP.’s own tally for this item (“Elect Director: Anna U. Loengard, M.D.”): 976,901,062 for, 20,121,520 withheld, per its Form 8-K filed 2025-06-12 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Share-of-outstanding not shown: votes cast exceed the reported share count, which usually means multiple share classes with different voting rights.

The 22 asset managers below cast 100% of the shares they voted on this item FOR (30,055,289 for, 0 against).

FOR 91%9%
FOR: 30,055,289 (91.5%)ABSTAIN: 2,800,077 (8.5%)
Largest asset managers voting on “DIRECTOR: ANNA U. LOENGARD, M.D.” at CLOVER HEALTH INVESTMENTS CORP., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard20,087,8090 00For
Fidelity4,554,9280 00For
Charles Schwab2,642,6150 00For
First Trust00 1,495,3710Abstain
Invesco1,123,6630 00For
American Century00 914,9270Abstain
BlackRock687,6860 00For
State Street472,3400 1,4770For
Victory Capital00 381,2980Abstain
JPMorgan133,8020 00For
NORTHERN LIGHTS FUND TRUST III126,0510 00For
Cambria ETF Trust115,5140 00For
Advisor Managed Portfolios45,5570 00For
MASTER INVESTMENT PORTFOLIO31,9500 00For
Goldman Sachs23,5480 00For
John Hancock00 6,9100Abstain
Innovator ETFs Trust3,2870 00For
Northern Trust2,8260 00For
WILSHIRE MUTUAL FUNDS INC1,8470 00For
Advisors' Inner Circle Fund III1,5560 00For
RBB Fund Trust3100 00For
E Trade Trust00 940Abstain

3. DIRECTOR: WILLIAM G. ROBINSON JR.

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 4 wordings of this item as funds reported it.

97% Majority: yes · of votes cast

FOR 97%
FOR: 969,995,918WITHHELD: 27,026,664

CLOVER HEALTH INVESTMENTS CORP.’s own tally for this item (“Elect Director: William G. Robinson, Jr.”): 969,995,918 for, 27,026,664 withheld, per its Form 8-K filed 2025-06-12 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Share-of-outstanding not shown: votes cast exceed the reported share count, which usually means multiple share classes with different voting rights.

The 22 asset managers below cast 100% of the shares they voted on this item FOR (25,720,525 for, 0 against).

FOR 78%ABSTAIN 22%
FOR: 25,720,525 (78.3%)ABSTAIN: 7,134,841 (21.7%)
Largest asset managers voting on “DIRECTOR: WILLIAM G. ROBINSON JR.” at CLOVER HEALTH INVESTMENTS CORP., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard20,087,8090 00For
Fidelity222,9900 4,331,9380Abstain
Charles Schwab2,642,6150 00For
First Trust00 1,495,3710Abstain
Invesco1,123,6630 00For
American Century00 914,9270Abstain
BlackRock687,6860 00For
State Street472,3400 1,4770For
Victory Capital00 381,2980Abstain
JPMorgan133,8020 00For
NORTHERN LIGHTS FUND TRUST III126,0510 00For
Cambria ETF Trust115,5140 00For
Advisor Managed Portfolios45,5570 00For
MASTER INVESTMENT PORTFOLIO31,9500 00For
Goldman Sachs23,5480 00For
John Hancock00 6,9100Abstain
Innovator ETFs Trust3,2870 00For
Northern Trust00 2,8260Abstain
WILSHIRE MUTUAL FUNDS INC1,8470 00For
Advisors' Inner Circle Fund III1,5560 00For
RBB Fund Trust3100 00For
E Trade Trust00 940Abstain

4. THE RATIFICATION OF THE APPOINTMENT OF ERNST & YOUNG LLP AS THE COMPANY'S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM.

AUDIT-RELATEDMajority of the votes cast: yes

99.7% Majority: yes · of votes cast

FOR 99.7%
FOR: 1,154,406,035AGAINST: 3,060,080

CLOVER HEALTH INVESTMENTS CORP.’s own tally for this item (“Proposal 3: Ratification of the appointment of Ernst & Young LLP as independent registered public accounting firm for the fiscal year ending December 31, 2025”): 1,154,406,035 for, 3,060,080 against, per its Form 8-K filed 2025-06-12 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Share-of-outstanding not shown: votes cast exceed the reported share count, which usually means multiple share classes with different voting rights.

The 22 asset managers below cast 99.6% of the shares they voted on this item FOR (32,724,472 for, 130,894 against).

FOR 99.6%
FOR: 32,724,472 (99.6%)AGAINST: 130,894 (0.4%)
Largest asset managers voting on “THE RATIFICATION OF THE APPOINTMENT OF ERNST & YOUNG LLP AS THE COMPANY'S INDEPENDENT REGISTERED PUBLIC ACCOUN” at CLOVER HEALTH INVESTMENTS CORP., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard20,087,8090 00For
Fidelity4,554,9280 00For
Charles Schwab2,642,6150 00For
First Trust1,495,3710 00For
Invesco1,123,6630 00For
American Century914,9270 00For
BlackRock687,6860 00For
State Street473,8170 00For
Victory Capital381,2980 00For
JPMorgan133,8020 00For
NORTHERN LIGHTS FUND TRUST III0126,051 00Against
Cambria ETF Trust115,5140 00For
Advisor Managed Portfolios45,5570 00For
MASTER INVESTMENT PORTFOLIO31,9500 00For
Goldman Sachs23,5480 00For
John Hancock6,9100 00For
Innovator ETFs Trust03,287 00Against
Northern Trust2,8260 00For
WILSHIRE MUTUAL FUNDS INC1,8470 00For
Advisors' Inner Circle Fund III01,556 00Against
RBB Fund Trust3100 00For
E Trade Trust940 00For

Largest CLOVER HEALTH INVESTMENTS CORP. shareholders voting in 2024-2025

Ranked by the number of CLOVER HEALTH INVESTMENTS CORP. shares each manager voted on the most widely held ballot item of the 2024-2025 meeting, shown as a share of the 497,056,331 shares outstanding at the time of that meeting.

Top CLOVER HEALTH INVESTMENTS CORP. shareholders by shares voted, 2024-2025
#Asset manager % of shares outstanding
1Vanguard 4.19%
2Renaissance 1.77%
3BlackRock 1.69%
4Charles Schwab 1.06%
5GEODE CAPITAL MANAGEMENT, LLC 1.02%
6Fidelity 0.92%
7State Street 0.62%
8MARSHALL WACE, LLP 0.52%
9Invesco 0.45%
10American Century 0.37%

Reported CLOVER HEALTH INVESTMENTS CORP. ownership

Positions disclosed to the SEC on Schedules 13D and 13G, Form 13F and the company’s own proxy statement (DEF 14A).

CLOVER HEALTH INVESTMENTS CORP. beneficial owners on record for the 2024-2025 proxy season
Holder % outstanding Disclosure
Entities affiliated with Vivek Garipalli 16.82% DEF14A
Vanguard Group 4.14% 13F
Renaissance Technologies 2.22% 13F
BlackRock 2.09% 13F
Millennium Management 1.17% 13F
Geode Capital 1.01% 13F
Andrew Toy 0.86% DEF14A
Citadel Advisors 0.65% 13F
State Street 0.59% 13F
Charles Schwab 0.53% 13F

Percentages above are of 497,056,331 shares outstanding, as reported by CLOVER HEALTH INVESTMENTS CORP. on its Form 10-Q dated 2025-03-31 (see the filing on EDGAR). This is the count contemporaneous with the 2024-2025 meeting, so the percentages are the ones that were true then, not ones restated against today’s share count.

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered investment companies and institutional managers disclose how they voted every proxy, and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from CLOVER HEALTH INVESTMENTS CORP.’s 10-Q dated 2025-03-31. This page is a static snapshot rebuilt weekly on 02 October 2026; a live search always shows the current data.

At CLOVER HEALTH INVESTMENTS CORP.'s shareholder meeting held 2025-06-10, in the 2024-2025 proxy season, 130 asset managers reported how they voted on 4 ballot items in their SEC Form N-PX filings, covering 376 separate fund positions. On the most widely held item on that ballot — Non-binding advisory proposal to approve the compensation paid to our named executive officers… — FOR was 99.3% of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side), which is more than half. Whether the item was approved is for the filing to say; that statement has not been read for this item. Source: CLOVER HEALTH INVESTMENTS CORP.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on 2025-06-12.

CLOVER HEALTH INVESTMENTS CORP. proxy season coverage: 2023-2024 · 2024-2025 (this page) · 2025-2026.